Download or read book Biomarkers from Multi tracer and Multi modal Neuroimaging in Age related Neurodegenerative Diseases written by Ping Wu and published by Frontiers Media SA. This book was released on 2022-09-12 with total page 329 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Multimodal and Longitudinal Bioimaging Methods for Characterizing the Progressive Course of Dementia written by Javier Ramírez and published by Frontiers Media SA. This book was released on 2019-08-12 with total page 168 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Imaging and Multiomic Biomarker Applications written by Yongxia Zhou and published by Nova Medicine & Health. This book was released on 2021-01-20 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: The well-known Alzheimer's Disease Neuroimaging Initiative (ADNI) Center provides the most advanced, comprehensive, multiparametric and up-to-date biomarkers for mild cognitive impairment (MCI) and early Alzheimer's disease (AD) projects, including neuroimaging, clinical assessments, biospecimens and genetic data. Recent developments in imaging techniques, including new molecular tracers for imaging disease burden and systematic multi-modal integration, have emerged to overcome the limitations of each single modality and individual-dependent variability. The MRI-based high-resolution structural and morphological changes in the brain, such as atrophy, and the abnormal activity/connectivity patterns of the hippocampus subfields and default mode network (DMN) modulation, together with the amyloid and tau neuropathological quantification using PET molecular tracers, could be used to predict brain changes and cognitive performance declines in early AD, including transitional MCI. Finally, a generalized and integrative model with multiple biomarkers could be built to target disease progression and symptom prediction as well as to optimize patient management.Multiomics investigates metabolomic, lipidomic, genomic, transcriptomic and proteomic perspectives by presenting an accurate biochemical profile of the organism in health and disease. The Alzheimer's Disease Metabolomics Consortium (ADMC) in partnership with ADNI is creating a comprehensive biochemical database for patients in the ADNI1 cohort, consisting of eight metabolomics datasets. The vast majorities of biospecimen data provide rich biological information to the human brain at normal and dementia status. One of the purposes is to reveal the connections between disease and multiomics such as obesity, hypertension, cholesterol imbalance and inflammation risks that might lead to neurodegenerative disease. Multiomic biomarker developments in the dementia field have provided earlier clues to novel treatments that help correct metabolic dysfunction and delay disease progression. Furthermore, the assembling of multiomics-based biomarkers including metabolites and lipids, cholesterol biosynthesis, purine metabolism, lipoprotein, bile acids, and genetics as well as their relation to the pathological amyloid and tau network could improve disease diagnosis sensitivity and reveal more diverse and complementary molecular pathways to allow for the advancement of early AD diagnosis and therapeutic prevention. In this book, we report on the significant differences of multiple biomarkers from the ADNI database including neuroimaging, clinical assessments and multiomic biospecimen/genetic data in MCI and early probable AD (pAD), and elucidate the interconnections among different metrics at various domains. Classification results with high accuracies (0.95-1) for each early dementia subtype including early MCI (EMCI), late MCI (LMCI) and pAD, and better prediction of clinical symptoms is achieved with these comprehensive biomarkers. Further longitudinal changes of imaging and neuropsychological biomarkers, and inter-correlations with baseline parameters are examined for a better illustration of disease progression association. Additionally, an analysis of the post-traumatic stress disorder biomarkers is performed with high classification accuracy. With illustrative and rigorous data analyses and confirmative results, this book provides readers with a full spectrum of biomarker research for early dementia diagnosis and treatment, and helps convey the technical development and data evaluation perspectives in advanced medical imaging and various disease application fields.

Download or read book Multi scale and Multimodal Imaging Biomarkers for the Early Detection of Alzheimer s Disease written by Kilian Hett and published by . This book was released on 2019 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: Alzheimer's disease (AD) is the most common dementia leading to a neurodegenerative process and causing mental dysfunctions. According to the world health organization, the number of patients having AD will double in 20 years. Neuroimaging studies performed on AD patients revealed that structural brain alterations are advanced when the diagnosis is established. Indeed, the clinical symptoms of AD are preceded by brain changes. This stresses the need to develop new biomarkers to detect the first stages of the disease. The development of such biomarkers can make easier the design of clinical trials and therefore accelerate the development of new therapies. Over the past decades, the improvement of magnetic resonance imaging (MRI) has led to the development of new imaging biomarkers. Such biomarkers demonstrated their relevance for computer-aided diagnosis but have shown limited performances for AD prognosis. Recently, advanced biomarkers were proposed toimprove computer-aided prognosis. Among them, patch-based grading methods demonstrated competitive results to detect subtle modifications at the earliest stages of AD. Such methods have shown their ability to predict AD several years before the conversion to dementia. For these reasons, we have had a particular interest in patch-based grading methods. First, we studied patch-based grading methods for different anatomical scales (i.e., whole brain, hippocampus, and hippocampal subfields). We adapted patch-based grading method to different MRI modalities (i.e., anatomical MRI and diffusion-weighted MRI) and developed an adaptive fusion scheme. Then, we showed that patch comparisons are improved with the use of multi-directional derivative features. Finally, we proposed a new method based on a graph modeling that enables to combine information from inter-subjects' similarities and intra-subjects' variability. The conducted experiments demonstrate that our proposed method enable an improvement of AD detection and prediction.

Download or read book Modelling Imaging Biomarkers of Alzheimer s Disease Using Animal Models written by Maxime Parent and published by . This book was released on 2016 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: "Alzheimer's disease is a progressive neurodegenerative disorder characterized by brain amyloid-beta aggregating into plaques, intraneuronal neurofibrillary tangles and neuronal losses, eventually leading to cognitive decline and dementia. The complex interplay between these pathophysiological hallmarks is still not yet fully understood, and therapeutic approaches based on the current conceptualization of Alzheimer pathology have yet to yield potent disease-modifying treatments. To further our understanding of these pathological interactions and to guide therapeutic targets, two tools can be particularly helpful: imaging biomarkers, which allow the in vivo quantification of pathophysiological build-up and neurodegeneration even in the absence of clear clinical symptoms; and animal models, which can be used to study the specific expression of certain aspects of the pathology in a controlled environment.The combination of animal models with multimodal neuroimaging techniques provide a unique platform that can be used to test predictions generated by theoretical disease models and to validate new avenues for potential biomarkers and drug discovery. Here, we performed several studies highlighting the translational power of such approaches to further research on Alzheimer's disease pathophysiology.First, with a longitudinal and multimodal study using the McGill-R-Thy1-APP transgenic rat model of amyloid-beta pathology, we showed that even in the absence of neurofibrillary tangles or widespread neuronal death, amyloid-beta can induce marked neurodegeneration as measured with several PET and MRI markers as well as memory losses. Second, using the same transgenic model, we showed a beneficial effect of hippocampal microglial activation on memory and resting-state connectivity. Finally, using an immunolesioned rat model, we validated the use of [18F]FEOBV as a sensitive PET radiotracer able to measure specific losses of cholinergic synapses, and then confirmed these findings with [18F]FEOBV autoradiography in brain tissue of patients with Alzheimer's disease." --

Download or read book Mining Brain Imaging and Genetics Data Via Structured Sparse Learning written by Jingwen Yan and published by . This book was released on 2015 with total page 210 pages. Available in PDF, EPUB and Kindle. Book excerpt: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by gradual loss of brain functions, usually preceded by memory impairments. It has been widely affecting aging Americans over 65 old and listed as 6th leading cause of death. More importantly, unlike other diseases, loss of brain function in AD progression usually leads to the significant decline in self-care abilities. And this will undoubtedly exert a lot of pressure on family members, friends, communities and the whole society due to the time-consuming daily care and high health care expenditures. In the past decade, while deaths attributed to the number one cause, heart disease, has decreased 16 percent, deaths attributed to AD has increased 68 percent. And all of these situations will continue to deteriorate as the population ages during the next several decades. To prevent such health care crisis, substantial efforts have been made to help cure, slow or stop the progression of the disease. The massive data generated through these efforts, like multimodal neuroimaging scans as well as next generation sequences, provides unprecedented opportunities for researchers to look into the deep side of the disease, with more confidence and precision. While plenty of efforts have been made to pull in those existing machine learning and statistical models, the correlated structure and high dimensionality of imaging and genetics data are generally ignored or avoided through targeted analysis. Therefore their performances on imaging genetics study are quite limited and still have plenty to be improved. The primary contribution of this work lies in the development of novel prior knowledge-guided regression and association models, and their applications in various neurobiological problems, such as identification of cognitive performance related imaging biomarkers and imaging genetics associations. In summary, this work has achieved the following research goals: (1) Explore the multimodal imaging biomarkers toward various cognitive functions using group-guided learning algorithms, (2) Development and application of novel network structure guided sparse regression model, (3) Development and application of novel network structure guided sparse multivariate association model, and (4) Promotion of the computation efficiency through parallelization strategies.

Download or read book Neuroimaging in Dementia written by Frederik Barkhof and published by Springer Science & Business Media. This book was released on 2011-02-11 with total page 295 pages. Available in PDF, EPUB and Kindle. Book excerpt: This up-to-date, superbly illustrated book is a practical guide to the effective use of neuroimaging in the patient with cognitive decline. It sets out the key clinical and imaging features of the various causes of dementia and directs the reader from clinical presentation to neuroimaging and on to an accurate diagnosis whenever possible. After an introductory chapter on the clinical background, the available "toolbox" of structural and functional neuroimaging techniques is reviewed in detail, including CT, MRI and advanced MR techniques, SPECT and PET, and image analysis methods. The imaging findings in normal ageing are then discussed, followed by a series of chapters that carefully present and analyze the key findings in patients with dementias. Throughout, a practical approach is adopted, geared specifically to the needs of clinicians (neurologists, radiologists, psychiatrists, geriatricians) working in the field of dementia, for whom this book will prove an invaluable resource.

Download or read book Multi modality Inference Methods for Neuroimaging with Applications to Alzheimer s Disease Research written by and published by . This book was released on 2012 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: An emphasis in ongoing Alzheimer's disease (AD) research is identifying those biomarkers which best predict future cognitive decline at the various stages of disease progression. These biomarkers can then serve as early markers for diagnosis, and for selection of subjects into clinical trials. Recent results suggest that the identification of such discriminative biomarkers is possible by adapting machine learning methods for this problem: but studies have primarily used modalities in isolation so far. The sensitivity/specificity offered by these methods is unsatisfactory for more clinically relevant questions: which Mild Cognitive Impairment (MCI) patients will convert to AD? Answering such questions requires new methods that leverage all data sources (e.g., imaging modalities, CSF measures) in conjunction. This thesis focuses on how data from multiple biomarkers should be optimally aggregated to best predict future cognitive decline, and how these models can improve clinical trials for AD. Significant improvements in sensitivity and specificity for discriminating AD, MCI, and healthy controls at the level of individual subjects are possible by making use of multiple modalities (together with longitudinal data) simultaneously. Further, these methods significantly improve sample size estimates in clinical trials, and help derive customized outcomes for evaluating new treatment procedures. This dissertaion presents new algorithms for a) introducing inductive biases into existing machine learning methods which are designed to fully capture and exploit the structure of the image data; b) combining various imaging modalities into a single predictive model via constructions based on robust loss functions, and quadratic regularizers based on modality-modality interactions; c) using the above frameworks to derive sensitive custom measures of disease progressiong from medical neuroimaging data for use in clinical trials. We present extensive empirical evaluations and theoretical evidence that illustrate how tailor-made machine learning algorithms can transform neuroimaging analysis and clinical trials.

Download or read book Understanding Emerging Biomarkers and Lifestyle Factors in Aging and Alzheimer Disease written by Stephanie Ann Schultz and published by . This book was released on 2020 with total page 238 pages. Available in PDF, EPUB and Kindle. Book excerpt: Age-related cognitive decline and pathological brain changes are a widespread and growing public health issue. Several environmental factors, including engagement in physical activity and personality, have been shown to have potential protective effects in slowing cognitive decline and preserving healthy brain aging. However, the underlying mechanisms providing exercise- or personality-induced resilience to aging and disease remains largely unknown. Importantly, there has been an emergence of several novel biomarkers to study healthy brain aging and age-related neurodegenerative diseases including in vivo assessments of tau burden and brain metabolism via positron emission tomography (PET) imaging and neurofilament light chain (NfL), a marker of neurodegeneration, via Age-related cognitive decline and pathological brain changes are a widespread and growing public health issue. Several environmental factors, including engagement in physical activity and personality, have been shown to have potential protective effects in slowing cognitive decline and preserving healthy brain aging. However, the underlying mechanisms providing exercise- or personality-induced resilience to aging and disease remains largely unknown. Importantly, there has been an emergence of several novel biomarkers to study healthy brain aging and age-related neurodegenerative diseases including in vivo assessments of tau burden and brain metabolism via positron emission tomography (PET) imaging and neurofilament light chain (NfL), a marker of neurodegeneration, via blood-based biomarkers. During the first part of my thesis research, I examined these emerging biomarkers within healthy aging and AD cohorts at Washington University, in the Australian Imaging, Biomarkers, and Lifestyle (AIBL) cohort, and in the Dominantly Inherited Alzheimer Network (DIAN) observational study (Chapters 2 - 5). For the second part of my thesis research, I first used my new knowledge and experience with these biomarkers to characterize and determine the influence of physical activity on cerebral glucose metabolism (Chapter 6). Next, to better translate these findings to an exercise intervention in the future, I further completed a pilot study to determine feasibility and validity of performing a submaximal exercise protocol in a diverse US population (Chapter 7). For the third part of my thesis research, I discovered a cross-sectional association between personality traits and neurofibrillary tangle pathology. Taken together, the results from my thesis suggest utility in all three emerging biomarkers examined (tau-PET, blood-based NfL, and multi-tracer brain metabolism PET) for monitoring and understanding complex changes associated with brain aging and disease. Additionally, this thesis research adds to the current understanding of the potential role of increased physical activity in preservation of glycolytic metabolism in the aging brain and increased risk of AD-related tau pathophysiology in neurotic personality traits. Further research extending these findings to longitudinal studies are needed to help determine directionality of the observed effects.

Download or read book Neurodegenerative Diseases written by Shamim I. Ahmad and published by Springer Science & Business Media. This book was released on 2012-03-12 with total page 421 pages. Available in PDF, EPUB and Kindle. Book excerpt: The editor of this volume, having research interests in the field of ROS production and the damage to cellular systems, has identified a number of enzymes showing ·OH scavenging activities details of which are anticipated to be published in the near future as confirmatory experiments are awaited. It is hoped that the information presented in this book on NDs will stimulate both expert and novice researchers in the field with excellent overviews of the current status of research and pointers to future research goals. Clinicians, nurses as well as families and caregivers should also benefit from the material presented in handling and treating their specialised cases. Also the insights gained should be valuable for further understanding of the diseases at molecular levels and should lead to development of new biomarkers, novel diagnostic tools and more effective therapeutic drugs to treat the clinical problems raised by these devastating diseases.

Download or read book Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders written by Paul C. Guest and published by Springer. This book was released on 2019-02-12 with total page 328 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book includes a series of reviews on general aspects of biomarker use in the study of psychiatric and neurodegenerative diseases and the development of medications involved in their treatment. It describes the pros and cons of the various approaches and covers the successes and failures in this research field. It is only by a thorough understanding of the shortcomings that progress can be made. The overall goal is to facilitate the understanding and treatment of these disorders, by providing a viable mechanism of catching up with other areas of modern medicine, such as diabetes and heart disease. Finally, it is anticipated that the development and application of valid biomarker tests and the leveraging of novel drug targets will help the fields of psychiatry on neurodegenerative disorders move into the area of personalized medicine where the right patients can receive the right medication at the right time for the best possible outcome.

Download or read book Imaging in Neurodegenerative Disorders written by Luca Saba and published by Oxford University Press, USA. This book was released on 2015 with total page 585 pages. Available in PDF, EPUB and Kindle. Book excerpt: This text summarizes the latest developments in imaging techniques and other new diagnostic methods as applied to the neurodegenerative disorders.

Download or read book Neuroanatomy and Pathology of Sporadic Alzheimer s Disease written by Heiko Braak and published by Springer. This book was released on 2014-12-11 with total page 168 pages. Available in PDF, EPUB and Kindle. Book excerpt: As indicated by its title, this monograph deals chiefly with morphologically recognizable deviations from the normal anatomical condition of the human CNS. The AD-associated pathology is illustrated from its beginnings (sometimes even in childhood) to its final form, which is reached late in life. The AD process commences much earlier than the clinically recognizable phase of the disorder, and its timeline includes an extended preclinical phase. The further the pendulum swings away from the symptomatic final stages towards the early pathology, the more obvious the lesions become, although from a standpoint of severity they are more unremarkable and thus frequently overlooked during routine neuropathological assessment. For this reason, the authors deal with the hallmark lesions in the early phases of the AD process in considerable detail

Download or read book Cerebral Small Vessel Disease written by Leonardo Pantoni and published by Cambridge University Press. This book was released on 2014-05 with total page 375 pages. Available in PDF, EPUB and Kindle. Book excerpt: Up-to-date discussion of the etiology, diagnosis, treatment, and prevention of this common cause of stroke and cognitive impairment.

Download or read book Information Processing in Medical Imaging written by Marc Niethammer and published by Springer. This book was released on 2017-06-06 with total page 691 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book constitutes the proceedings of the 25th International Conference on Information Processing in Medical Imaging, IPMI 2017, held at the Appalachian State University, Boon, NC, USA, in June 2017. The 53 full papers presented in this volume were carefully reviewed and selected from 147 submissions. They were organized in topical sections named: analysis on manifolds; shape analysis; disease diagnosis/progression; brain networks an connectivity; diffusion imaging; quantitative imaging; imaging genomics; image registration; segmentation; general image analysis.

Download or read book Oxford Textbook of Cognitive Neurology and Dementia written by Masud Husain and published by Oxford University Press. This book was released on 2018-10-29 with total page 513 pages. Available in PDF, EPUB and Kindle. Book excerpt: This volume covers the dramatic developments that have occurred in basic neuroscience and clinical research in cognitive neurology and dementia. It is based on the clinical approach to the patient, and provides essential knowledge that is fundamental to clinical practice.

Download or read book Diffusion MRI written by Derek K Jones and published by Oxford University Press. This book was released on 2010-11-11 with total page 784 pages. Available in PDF, EPUB and Kindle. Book excerpt: Professor Derek Jones, a world authority on diffusion MRI, has assembled most of the world's leading scientists and clinicians developing and applying diffusion MRI to produce an authorship list that reads like a "Who's Who" of the field and an essential resource for those working with diffusion MRI. Destined to be a modern classic, this definitive and richly illustrated work covers all aspects of diffusion MRI from basic theory to clinical application. Oxford Clinical Neuroscience is a comprehensive, cross-searchable collection of resources offering quick and easy access to eleven of Oxford University Press's prestigious neuroscience texts. Joining Oxford Medicine Online these resources offer students, specialists and clinical researchers the best quality content in an easy-to-access format.